The CLARITY Act passed the Senate Banking Committee with a 15-9 vote, advancing crypto regulation in the U.S. The bipartisan support included two Democrats breaking ranks to vote with Republicans. The bill aims to establish clear regulatory frameworks for digital assets, which has driven a surge in crypto stocks and tokens like Bitcoin, XRP, and Ethereum. Next, the bill moves to the Senate floor for further negotiation and must be reconciled with the House version before becoming law, promising formal legalization and clearer rules for the crypto industry.
The oligonucleotide drug development pipeline is rapidly expanding, featuring over 600 candidates from more than 200 companies including Novartis, Amgen, and Alnylam. These therapies target genetic diseases, cancers, and rare disorders using advanced...
The global cervical cancer diagnostics market is projected to grow at a compound annual growth rate (CAGR) of about 5% from 2026 to 2034, expanding from $4.4 billion in 2025 to $7.1 billion by 2034. This growth is fueled by rising cervical cancer pre...
AT&T, Verizon, and T-Mobile have agreed to collaborate by pooling spectrum resources and investing jointly in satellite-enabled direct-to-device technology to reduce wireless dead zones, especially in rural and underserved areas. This partnership aim...
Keycard announced Keycard for Multi-Agent Apps, a platform enabling secure, delegated, session-based access for autonomous AI agents. This system allows each AI agent to have its own verifiable identity and limits access strictly to the task at hand,...
Impact Therapeutics, a biotech company specializing in precision cancer drugs, saw its shares double on the first day of trading in Hong Kong after an IPO that was oversubscribed over 2000 times. The company’s lead product, senaparib, is a PARP inhib...
